Dr. Dehm is Professor and Apogee Enterprises Chair in Cancer Research, Department of Laboratory Medicine and Pathology at the University Minnesota, Minneapolis. Dr. Dehm’s research laboratory focuses on the role of the androgen receptor (AR) and alterations in AR signaling in prostate cancer development and progression, studying the changes that occur in the AR in response to drug therapies to understand the mechanisms underlying the progression to therapy-resistant disease. His work has revealed new ways in which cancer cells can re-activate the androgen/AR pathway. Dr. Dehm completed a BS and Ph.D. in Biochemistry at the University of Saskatchewan was a Postdoctoral Fellow at the Mayo Clinic.